menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

ARCH BIOPARTNERS I (ACHFF)
0.372 0 (0%)  01-11 14:58
Open: 0 Prev Close: 0.372
High: 0 Low: 0
Volume: 0 Market Cap: 20M
Year High: 0 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 0.4061    One year: 0.4333
Supports Support1: 0.3100   Support2: 0.2579
Resistances Resistance1: 0.3477    Resistance2: 0.3710 
Pivot Point 0.3364 
Moving Averages MA(5): 0.3238      MA(20):  

MA(100):   0     MA(250):  
MACD MACD(12,26): -10000000000.000  -10000000000    Signal(12,26,9): -10000000000.000  -10000000000
Stochastic Oscillator %K(14,3): 18.172      %D(3): -10000000000.000  -10000000000
RSI RSI(14): 35.043 
52-Week High: 0.3710  Low: 0.3100  Change(%): -12
Average Volume(K) 3-Month: -10000000000  10-Days: 4
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 17.6%; Bollinger Bands are 0% narrower than normal.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Arch Biopartners Initiates Manufacturing Process for Metablok
Tue, 10 Oct 2017 10:30:00 GMT

Arch Biopartners Inc. Opens the Market
Mon, 30 Mar 2015 15:36:02 GMT

Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start ...
Wed, 06 Dec 2017 15:00:00 GMT

Arch Biopartners Announces Non-Brokered Private Placement Financing
Tue, 21 Feb 2017 13:30:00 GMT

Arch Biopartners Engages Nucro Technics to Begin Toxicology Studies for Metablok
Wed, 01 Nov 2017 14:03:45 GMT

Arch Biopartners Inc.
Sun, 02 Apr 2017 14:52:02 GMT

Arch Biopartners Appoints Adrian Haigh to Board of Directors
Thu, 21 Aug 2014 12:22:30 GMT

Arch Biopartners' GMP Manufacturing of AB569 Progresses to Final Production Stage
Thu, 28 Sep 2017 12:22:30 GMT

Arch Biopartners Provides Update on GMP Manufacturing of AB569
Thu, 27 Jul 2017 16:41:15 GMT

Arch Biopartners Readies AB569, Potential Therapy for Lung Infections, for ...
Tue, 12 Dec 2017 13:00:05 GMT